Notice of Change to RFA-HD-24-010 "National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional)"
Notice NOT-HD-23-026 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 3, 2023 Category: Research Source Type: funding

National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional)
Funding Opportunity RFA-HD-24-010 from the NIH Guide for Grants and Contracts. TheEunice Kennedy ShriverNational Institute of Child Health and Human Development (NICHD), through the Fertility and Infertility (FI) Branch, provides funding for a limited number of research centers in the reproductive sciences. These centers provide an arena for multidisciplinary interactions among basic and clinical scientists interested in establishing high quality translational research programs in these scientific areas. The purpose of this NOFO is to announce the re-competition of the National Centers for Translational Research in Repr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 17, 2023 Category: Research Source Type: funding

Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
Notice NOT-OD-23-147 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 3, 2023 Category: Research Source Type: funding

Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Animal Species (R01)
The objective of this FOA is to encourage optimal utilization of large domestic animals in high-priority areas of biomedical and agricultural research. This initiative is designed to facilitate and encourage carefully designed research studies through meticulous selection of farm animals that mimic human developmental, physiological, and etiological processes to better understand the biology of normal reproduction and reproductive pathophysiology, normal and abnormal metabolism, developmental origin of diseases, precision nutrition, and improve prevention and treatment of diseases in both human and agriculturally important...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 11, 2022 Category: Research Source Type: funding

Physiomimetics and Organoids for Reproductive Health (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-23-024 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications to develop physiomimetic platforms and organoid culture systems for studies of the female reproductive tract and gametogenesis (both male and female) that can be used to uncover factors responsible for gynecological conditions and infertility. This FOA is intended to provide support for the further development of projects where preliminary data supports the feasibility of the line of investigation. Applicants without preliminary data may wish to apply to the companion R21 ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 22, 2022 Category: Research Source Type: funding

Physiomimetics and Organoids for Reproductive Health (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-23-025 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications to develop physiomimetic platforms and organoid culture systems for studies of the female reproductive tract and gametogenesis (both male and female) that can be used to uncover factors responsible for gynecological conditions and infertility. The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. High risk/high reward projects that lack preliminary data may be mos...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 22, 2022 Category: Research Source Type: funding

Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
Notice NOT-OD-22-152 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 30, 2022 Category: Research Source Type: funding

National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50) (Clinical Trial Optional)
Funding Opportunity RFA-HD-23-011 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to announce the re-competition of the National Centers for Translational Research in Reproduction and Infertility (NCTRI). The NCTRI will be administered through the Specialized Research Center (P50) award mechanism. These centers will form a national network that facilitates and accelerates bidirectional knowledge transfer between the laboratory and clinic with the ultimate goal of improving human reproductive health through research excellence and innovation. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 17, 2022 Category: Research Source Type: funding

Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
Notice NOT-OD-21-143 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 21, 2021 Category: Research Source Type: funding

Biomarker Research to Support Fertility Regulation Development by Small Business (R43 Clinical Trial Optional)
Funding Opportunity RFA-HD-22-018 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved clinical biomarkers and companion biomarker diagnostics (e.g., point of care and/or direct-to-consumer tests, DTC) to support the clinical development of non-hormonal contraceptive product(s) for men and women. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 15, 2021 Category: Research Source Type: funding

Technologies to Advance Precision Medicine for Reproductive Health and Infertility (R43, R44 Clinical Trial Optional)
Funding Opportunity RFA-HD-22-010 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage the small business community to collaborate with scientists and clinicians in the fields of female and male reproductive medicine, infertility, andrology/urology, and gynecology to develop, adapt and validate discoveries in genomics, epigenomics, metabolomics and biomarkers to the clinical diagnosis and treatment of women and men with infertility, and diseases and disorders that affect fertility. The ultimate goal is to advance the application of precision medicine to ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 31, 2021 Category: Research Source Type: funding

Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional)
Funding Opportunity PAR-20-281 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity (FOA) is to support research that explores the premise that fertility status can be a marker for overall health. Chronic conditions such as concer, diabetes, and obesity can impair fertility, however, less is known about the extent to which fertility status can impact or acts as a marker for overall health. Data suggest that infertility is not necessarily a unique disease of the reproductive axis but is often physiologically or genetically linked with other diseases and conditions. Recent epidemiologic stu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 23, 2020 Category: Research Source Type: funding

Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-282 from the NIH Guide for Grants and Contracts. T?he purpose of this funding opportunity announcement (FOA) is to support exploratory/developmental research that explores the premise that fertility status can be a marker for overall health. Chronic conditions such as cancer, diabetes, and obesity can impair fertility, however, less is known about the extent to which fertility status can impact or act as a marker for overall health. Data suggest that infertility is not necessarily a unique disease of the reproductive axis but is often physiologically or genetically linked with other diseases a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 23, 2020 Category: Research Source Type: funding

Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
Notice NOT-OD-20-135 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 16, 2020 Category: Research Source Type: funding

Development of Fertility Regulation Methods by Small Business (R43/R44 Clinical Trial Optional)
Funding Opportunity RFA-HD-21-007 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to invite SBIR applications to support and facilitate the development of new and/or improved non-hormonal contraceptive, including contraceptives with anti-infective properties, products for men and women. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 10, 2020 Category: Research Source Type: funding